Optain, founded in New York City, is dedicated to making healthcare accessible to everyone through innovative medical equipment and software. The company's core mission is to utilize artificial intelligence to create affordable clinical assistance solutions, simplifying illness screening processes for use anytime and anywhere. Optain's flagship products include non-invasive clinical support tools that analyze full-color retinal images using AI-enabled algorithms to screen for referable diseases and evaluate overall patient health.

Notable figures associated with Optain include leading AI researchers and healthcare professionals who contribute to the development of their cutting-edge technology. The company has attracted significant investment from prominent venture capital firms focused on healthcare innovation. Key achievements include the successful deployment of their AI-driven retinal imaging tools in various clinical settings, significantly improving early disease detection rates. Optain's impact lies in its ability to democratize access to essential health diagnostics, ultimately aiming to enhance the quality of life for people worldwide.